Cargando…

Poor Outcomes in Patients With Transplant Glomerulopathy Independent of Banff Categorization or Therapeutic Interventions

BACKGROUND: Transplant glomerulopathy (TG) may indicate different disease entities including chronic AMR (antibody-mediated rejection). However, AMR criteria have been frequently changed, and long-term outcomes of allografts with AMR and TG according to Banff 2017 have rarely been investigated. METH...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wu, Kaiyin, Schmidt, Danilo, López del Moral, Covadonga, Osmanodja, Bilgin, Lachmann, Nils, Halleck, Fabian, Choi, Mira, Bachmann, Friederike, Ronicke, Simon, Duettmann, Wiebke, Naik, Marcel, Schrezenmeier, Eva, Rudolph, Birgit, Budde, Klemens
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9133540/ https://www.ncbi.nlm.nih.gov/pubmed/35646957 http://dx.doi.org/10.3389/fmed.2022.889648

Ejemplares similares

Poor Long-Term Renal Allograft Survival in Patients with Chronic Antibody-Mediated Rejection, Irrespective of Treatment—A Single Center Retrospective Study
por: Wu, Kaiyin, et al.
Publicado: (2021)

The natural history of de novo donor-specific HLA antibodies after kidney transplantation
por: López del Moral, Covadonga, et al.
Publicado: (2022)

Clinicopathologic Features and Risk Factors of Proteinuria in Transplant Glomerulopathy
por: Zhang, Qiang, et al.
Publicado: (2021)

A single centre in-depth analysis of death with a functioning kidney graft and reasons for overall graft failure
por: Mayrdorfer, Manuel, et al.
Publicado: (2022)

Initial Experience With SARS-CoV-2-Neutralizing Monoclonal Antibodies in Kidney or Combined Kidney-Pancreas Transplant Recipients
por: Bachmann, Friederike, et al.
Publicado: (2022)

COVID-19 Outcomes in Kidney Transplant Recipients in a German Transplant Center
por: Mikhailov, Michael, et al.
Publicado: (2023)

Influence of Belatacept- vs. CNI-Based Immunosuppression on Vascular Stiffness and Body Composition
por: Heleniak, Zbigniew, et al.
Publicado: (2022)

Declining Course of Humoral Immune Response in Initially Responding Kidney Transplant Recipients after Repeated SARS-CoV-2 Vaccination
por: Ronicke, Simon, et al.
Publicado: (2022)

Evaluation of a clinical decision support system for detection of patients at risk after kidney transplantation
por: Roller, Roland, et al.
Publicado: (2022)

When performance is not enough—A multidisciplinary view on clinical decision support
por: Roller, Roland, et al.
Publicado: (2023)

Low Seroprevalence of SARS-CoV-2 Antibodies during Systematic Antibody Screening and Serum Responses in Patients after COVID-19 in a German Transplant Center
por: Choi, Mira, et al.
Publicado: (2020)

Serological Response to Three, Four and Five Doses of SARS-CoV-2 Vaccine in Kidney Transplant Recipients
por: Osmanodja, Bilgin, et al.
Publicado: (2022)

Rituximab in Combination With Bortezomib, Plasmapheresis, and High-Dose IVIG to Treat Antibody-Mediated Renal Allograft Rejection
por: Waiser, Johannes, et al.
Publicado: (2016)

Temporary antimetabolite treatment hold boosts SARS-CoV-2 vaccination–specific humoral and cellular immunity in kidney transplant recipients
por: Schrezenmeier, Eva, et al.
Publicado: (2022)

Pregnancy after Kidney Transplantation—Impact of Functional Renal Reserve, Slope of eGFR before Pregnancy, and Intensity of Immunosuppression on Kidney Function and Maternal Health
por: Kaatz, Rebecca, et al.
Publicado: (2023)

“Nothing works without the doctor:” Physicians’ perception of clinical decision-making and artificial intelligence
por: Samhammer, David, et al.
Publicado: (2022)

Absolute or Relative Quantification of Donor-derived Cell-free DNA in Kidney Transplant Recipients: Case Series
por: Osmanodja, Bilgin, et al.
Publicado: (2021)

Microvascular inflammation is a risk factor in kidney transplant recipients with very late conversion from calcineurin inhibitor-based regimens to belatacept
por: Choi, Mira, et al.
Publicado: (2020)

Pan-Genotype Pre-Exposure Prophylaxis (PrEP) Allows Transplantation of HCV-Positive Donor Kidneys to Negative Transplant Recipients
por: Duerr, Michael, et al.
Publicado: (2020)

Development and validation of multivariable prediction models of serological response to SARS-CoV-2 vaccination in kidney transplant recipients
por: Osmanodja, Bilgin, et al.
Publicado: (2022)

First diagnosis of thrombotic thrombocytopenic purpura after SARS-CoV-2 vaccine – case report
por: Osmanodja, Bilgin, et al.
Publicado: (2021)

Correction to: The underestimated burden of monogenic kidney disease in adults waitlisted for kidney transplantation
por: Schrezenmeier, Eva, et al.
Publicado: (2021)

The underestimated burden of monogenic kidney disease in adults waitlisted for kidney transplantation
por: Schrezenmeier, Eva, et al.
Publicado: (2021)

Assessment of Renal Transplant Perfusion by Contrast-Enhanced Ultrasound after Switch from Calcineurin Inhibitor to Belatacept: A Pilot Study
por: Osmanodja, Bilgin, et al.
Publicado: (2022)

Donor-Derived Cell-Free DNA in Biopsy-Proven Antibody-Mediated Rejection Versus Recurrent IgA Nephropathy After Kidney Transplantation
por: Akifova, Aylin, et al.
Publicado: (2023)

Banff Challenge 2
por: Junk, Thomas R
Publicado: (2011)

De-novo malignancies after kidney transplantation: A long-term observational study
por: Fröhlich, Felix A., et al.
Publicado: (2020)

Donor-Derived Cell-Free DNA for Kidney Allograft Surveillance after Conversion to Belatacept: Prospective Pilot Study
por: Osmanodja, Bilgin, et al.
Publicado: (2023)

Remote Patient Management May Reduce All-Cause Mortality in Patients With Heart-Failure and Renal Impairment
por: Naik, Marcel G., et al.
Publicado: (2022)

Donor-derived cell-free DNA as a diagnostic tool in transplantation
por: Oellerich, Michael, et al.
Publicado: (2022)

Hot hodgepodge: Banff, 1993
por: Pisarski, R D
Publicado: (1994)

Banff Challenge 2 - signal significance
por: Junk, Tom
Publicado: (2011)

Open issues in the wake of Banff 2010
por: Demortier, Luc, et al.
Publicado: (2011)

Banff Summer Institute on Particles and Fields
por: Boal, David H, et al.
Publicado: (1978)

Banff Summer Institute on Particles and Fields
por: Capri, Anton Z, et al.
Publicado: (1983)

Review of the Banff Challenge on Upper Limits
por: Joel Heinrich
Publicado: (2007)

Review of the Banff Challenges on Upper Limits
por: Heinrich, Joel
Publicado: (2008)

Open issues in the wake of Banff 2010
por: Demortier, Luc
Publicado: (2011)

Dr John Charles Hirschfeld of Banff
Publicado: (1880)

Classifying Polyomavirus Nephropathy: The “Banff” Initiative
por: Nickeleit, Volker, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_7tmvg0me28q4e80k25i441m4sc